Liver mass screening: Difference between revisions

Jump to navigation Jump to search
(Mahshid)
Line 4: Line 4:


==Overview==
==Overview==
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for liver mass.<ref name="US">Recommendations. US preventive services task force(2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=liver+mass Accessed on March, 24th 2016</ref>
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for benign liver mass. However, routine screening is recommended for individuals with [[HBV infection|chronic hepatitis B virus infection]] or [[cirrhosis]] from any cause who are at risk for development of [[Hepatocellular carcinoma|HCC]] by ultrasound every 6 months.


==Screening==
==Screening==
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for liver mass.<ref name="US">Recommendations. US preventive services task force(2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=liver+mass Accessed on March, 24th 2016</ref>  
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for benign liver mass. However, routine screening is recommended for individuals with [[HBV infection|chronic hepatitis B virus infection]] or [[cirrhosis]] from any cause who are at risk for development of [[Hepatocellular carcinoma|HCC]] by ultrasound every 6 months. <ref name="US">Recommendations. US preventive services task force(2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=liver+mass Accessed on March, 24th 2016</ref>
 
==== Recommended High-Risk Population for Screening for Hepatocellular Carcinoma ====
* '''Patients with Chronic Hepatitis B Virus Infection (HBsAg positivity)'''
** Asian males over 40 years of age
** Asian females over 50 years of age
** Africans over 20 years of age
** Patients with a family history of [[hepatocellular carcinoma]]
** Patients with high [[Hepatitis B virus|HBV]] viral loads
** Patients with evidence of active [[hepatitis]]
* '''Patients with Cirrhosis of Any Cause'''
** [[Chronic hepatitis B]]
** [[Chronic hepatitis C]]
** [[Alcoholic cirrhosis]]
** [[Non-alcoholic steatohepatitis]]
** [[Hereditary hemochromatosis]]
** [[Autoimmune hepatitis]]
** [[Primary biliary cirrhosis]]
** [[Alpha-1 antitrypsin deficiency]]


==References==
==References==
{{Reflist|1}}
{{Reflist|1}}
[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]

Revision as of 16:12, 31 January 2018

Liver Mass Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differential Diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Evaluation of Liver Mass

Staging

History and Symptoms

Physical Examination

Laboratory Studies

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Liver mass screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Liver mass screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Liver mass screening

CDC on Liver mass screening

Liver mass screening in the news

Blogs on Liver mass screening

Directions to Hospitals Treating bone or soft tissue mass

Risk calculators and risk factors for Liver mass screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for benign liver mass. However, routine screening is recommended for individuals with chronic hepatitis B virus infection or cirrhosis from any cause who are at risk for development of HCC by ultrasound every 6 months.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for benign liver mass. However, routine screening is recommended for individuals with chronic hepatitis B virus infection or cirrhosis from any cause who are at risk for development of HCC by ultrasound every 6 months. [1]

Recommended High-Risk Population for Screening for Hepatocellular Carcinoma

References

  1. Recommendations. US preventive services task force(2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=liver+mass Accessed on March, 24th 2016